You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MTD

Showing 26 - 50 of 8,801
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Tumors Trial in San Francisco, Chicago (350 mg leronlimab, 525 mg leronlimab, 700 mg leronlimab)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • 350 mg leronlimab
  • +4 more
  • San Francisco, California
  • +1 more
Mar 18, 2022

Metastatic Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma, Inoperable Disease Trial in Denmark, Germany

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aalborg, Denmark
  • +3 more
Dec 28, 2021

Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +4 more
  • Aurora, Colorado
  • +2 more
Apr 18, 2022

Epithelial Carcinoma, Solid Tumor Trial in United States (SYN125, SYN004)

Recruiting
  • Epithelial Carcinoma
  • Solid Tumor
  • SYN125
  • SYN004
  • Fairway, Kansas
  • +3 more
Jun 10, 2021

Solid Tumor Trial in Boston, Buffalo, San Antonio (Oraxol)

Completed
  • Solid Tumor
  • Boston, Massachusetts
  • +2 more
Sep 6, 2021

Advanced Solid Tumor Trial in Seoul (ABL501)

Recruiting
  • Advanced Solid Tumor
  • Seoul, Korea, Republic of
  • +3 more
Oct 31, 2021

Advanced Solid Tumor Trial in United States (ABL503)

Recruiting
  • Advanced Solid Tumor
  • Duarte, California
  • +4 more
Oct 5, 2021

Advanced Solid Tumors Trial in Seoul (NYH817G, NYH100P, NYH817G and NYH100P)

Unknown status
  • Advanced Solid Tumors
  • Seoul, Korea, Republic of
    Severance Hospital
Oct 19, 2020

Tumors Trial in Switzerland (BAL101553, BAL101553 at MTD)

Completed
Has Results
  • Neoplasms
  • Bellinzona, Switzerland
  • +5 more
Sep 14, 2021

Solid Tumor, Adult Trial in United States (LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER,

Recruiting
  • Solid Tumor, Adult
  • Lymphoma
  • LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER
  • Pembrolizumab - anti-PD-1 antibody
  • Los Angeles, California
  • +7 more
Oct 11, 2021

Advanced or Metastatic Solid Tumor Trial in Worldwide (Rogaratinib (BAY1163877), Copanlisib (BAY80-6946))

Completed
  • Advanced or Metastatic Solid Tumor
  • Rogaratinib (BAY1163877)
  • Copanlisib (BAY80-6946)
  • Los Angeles, California
  • +19 more
Jul 13, 2022

Solid Tumor Trial in Los Angeles (laboratory biomarker analysis, pharmacological study, recombinant albumin fusion protein

Active, not recruiting
  • Unspecified Adult Solid Tumor, Protocol Specific
  • laboratory biomarker analysis
  • +2 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Apr 1, 2021

Solid Tumor, Adult Trial in Houston (KA2507)

Completed
  • Solid Tumor, Adult
  • Houston, Texas
    M D Anderson
Aug 18, 2020

Multiple Myeloma Trial in Milwaukee (MLN9708, Dexamethasone, Bendamustine (multiple dose levels))

Completed
Has Results
  • Multiple Myeloma
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Sep 30, 2020

Tumors Trial in Taipei (188Re-BMEDA-liposome)

Terminated
  • Tumors
  • 188Re-BMEDA-liposome
  • Taipei, Taiwan
    Taipei Veterans General Hospital (Taiwain)
Jul 28, 2020

Intractable Cancer Pain Trial in United States (Resiniferatoxin)

Completed
  • Intractable Cancer Pain
  • Miami, Florida
  • +3 more
Oct 19, 2020

Solid Tumor, Adult, Triple Negative Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (AVID100 IV)

Terminated
  • Solid Tumor, Adult
  • +3 more
  • AVID100 IV
  • New Haven, Connecticut
  • +9 more
Mar 22, 2021

Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial in Shreveport (MTD of Velcade, Nipent and Rituxan

Withdrawn
  • Follicular Lymphoma
  • +2 more
  • MTD of Velcade, Nipent and Rituxan established in Part 1
  • Shreveport, Louisiana
    LSU - Shreveport Health Sciences Center, Feist-Weiller Cancer Ce
Aug 28, 2020

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (AUY922, Bortezomib, Dexamethasone)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • Scottsdale, Arizona
  • +8 more
Dec 11, 2020

Neuroectodermal Tumors, Rhabdomyosarcoma Trial in Worldwide (afatinib)

Completed
Has Results
  • Neuroectodermal Tumors
  • Rhabdomyosarcoma
  • Boston, Massachusetts
  • +27 more
Mar 3, 2021

Sickle Cell Anemia, Sickle Cell Disease, Malaria Trial in Kampala (Hydroxyurea)

Completed
  • Sickle Cell Anemia
  • +2 more
  • Kampala, Uganda
    Mulago Hospital Sickle Cell Clinic
Feb 19, 2020

Colorectal Cancer Trial in Houston (Azacitidine, Capecitabine, Oxaliplatin)

Completed
Has Results
  • Colorectal Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 3, 2020

Breast Cancer, Hematologic Tumors Trial in Worldwide (AUY922 2 mg/m2)

Completed
  • Breast Cancer
  • Hematologic Neoplasms
  • AUY922 2 mg/m2
  • Los Angeles, California
  • +9 more
Dec 11, 2020

Pain, Postoperative, Depression, Postpartum Trial in Pittsburgh (Dose Level 1, Dose Level 2, Dose Level 3)

Not yet recruiting
  • Pain, Postoperative
  • Depression, Postpartum
  • Dose Level 1
  • +3 more
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital of UPMC
Jun 7, 2023

HIV Trial in Boston (PGDM1400/Placebo (3mg/kg IV), PGDM1400/Placebo (10mg/kg IV), PGDM1400/Placebo (30mg/kg IV))

Completed
  • HIV Infections
  • PGDM1400/Placebo (3mg/kg IV)
  • +7 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 11, 2020